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TO THE EDITOR
Junctional epidermolysis bullosa (JEB) is
a group of genodermatoses character-
ized by clefting in the epidermal base-
ment membrane owing to absent or
defective anchoring proteins. If the het-
erotrimer laminin-332 is absent, affected
individuals suffer from widespread blis-
tering and erosions of skin and mucous
membranes with exuberant granulation
tissue and usually die within the first
year of life (Herlitz type of JEB). If
laminin-332 is produced but defective,
life expectancy may be almost normal
despite considerable blistering (non-
Herlitz JEB; Mu¨hle et al., 2005; Fine
et al., 2008). Mutations in the gene
LAMB3 affecting the b3 chain of
laminin-332 most frequently underlie
JEB (Schneider et al., 2007).
So far, treatment of JEB has only been
supportive. Future therapeutic options
may arise from bone marrow stem cells
(Tolar et al., 2009) or from gene therapy,
e.g., by means of autologous epidermal
stem cells modified ex vivo (Mavilio
et al., 2006; Di Nunzio et al., 2008) or
by prenatal gene transfer (Mu¨hle et al.,
2006; Endo et al., 2012). Before clinical
application, such therapeutic approa-
ches have to be evaluated in animals.
Mouse models lacking the a3, b3, or g2
chain of laminin-332 exist (Kuster et al.,
1997; Ryan et al., 1999; Meng et al.,
2003), but affected animals die shortly
after birth. Thus, long-term effects of
therapeutic approaches cannot be eva-
luated in these models (Mu¨hle et al.,
2006). There is one mouse strain with
a hypomorphic mutation of LAMC2
resulting in non-Herlitz JEB in homo-
zygous animals (Bubier et al., 2010);
however, LAMC2 mutations cause
only a minority of human JEB cases
(Schneider et al., 2007). A mouse
model with a defective LAMB3 gene thatAccepted article preview online 28 October 2014; published online 4 December 2014
Abbreviations: cDNA, complementary DNA; JEB, junctional epidermolysis bullosa; PTC, premature
termination codon
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would be suitable for evaluating novel
treatments is still missing. We aimed at
generating such a JEB model by knockin
of the point mutation c.628G4A
(p.E210K) in LAMB3 (www.ensembl.org:
gene ENSMUSG00000026639, transcript
ID ENSMUST00000016315). This muta-
tion is located in a highly conserved
region, and it occurs frequently in
humans, where it causes moderate skin
blistering without reduced life expec-
tancy (Schneider et al., 2007). It was
introduced into the murine LAMB3 gene
by gene targeting techniques (detailed
information provided in Supplementary
Information online), and heterozygous
LAMB3 628G4A knockin mice were
bred. All experimental procedures were
conducted in accordance with the legal
requirements and were approved by the
local government authorities.
A total of 14 homozygous LAMB3
628G4A knockin mice were observed
closely after birth. Eleven of them were
easily distinguishable from their litter-
mates, because they showed blistering
and erosions of the abdominal skin,
paws, or the tail tip (Figure 1a). Blistering
was neither observed in wild-type nor in
heterozygous LAMB3 628G4A mice.
Four knockin mice displayed blisters
already at the first examination. In the
other animals, blisters developed within
the first 2 days of life. Skin erosions
affected 5–25% of the total body surface
(Table 1). Affected pups lost up to 13%
of body weight, as determined at the
first examination (Table 1). Two animals
with typical epidermolysis phenotype
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Figure 1. Phenotypic and molecular characteristics of LAMB3 628G4A knockin mice. (a) Homozygous LAMB3 628G4A knockin mouse at the age of 30 hours.
Arrows indicate blistering. (b) Hematoxylin and eosin stained sections of skin (top row) and oral mucous membranes (bottom row) of homozygous knockin and
healthy control mice. (c) Schematic view of the LAMB3 complementary DNA (cDNA) portion investigated. (d) Analysis of LAMB3 expression in wild-type (wt),
heterozygous, and homozygous knockin (ki) mice. Quantitative PCR was performed with three independent cDNA samples of each genotype. Data were
normalized to porphobilinogen deaminase gene expression. The graph displays mean±SD. (e) PCR analysis of cDNA exons 6–9 (primers depicted above). (f)
Electropherogram of the exon 6/7 intersection in the PCR products displayed in e. (g) Immunofluorescence analysis of skin sections of healthy control (left) and
homozygous knockin mice (right) with antibodies recognizing the laminin-332 a3 and b3 chains or collagen VII (bar ¼ 50mm).
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were abandoned and cannibalized by
their mothers before material for further
analysis could be retained. One homo-
zygous LAMB3 628G4A knockin
mouse did not have any macroscopi-
cally detectable skin erosions, but it died
within 2 hours; the genotype was con-
firmed postmortem. Two other affected
mice were found dead at the first exam-
ination. None of the 14 homozygous
LAMB3 628G4A mice survived the first
3 days of life (Table 1). Six of them were
killed to retain material for further
analysis—two at an age of 448 hours
and three on the second day of life.
In homozygous LAMB3 628G4A
mice, histological sections of skin and
oral mucous membranes showed irregu-
lar clefting at the dermo-epidermal junc-
tion (Figure 1b), which was not seen
in control mice. Immunofluorescence
staining of skin sections from homozy-
gous knockin mice indicated complete
absence of the a3 and b3 chains of
laminin-332, whereas collagen VII was
not diminished (Figure 1g).
Complementary DNA (cDNA) of
LAMB3 628G4A knockin and control
mice was used to quantify LAMB3 trans-
cription by quantitative reverse trans-
criptase real-time PCR. The expected
PCR product spans 146 bp between
LAMB3 exons 10 and 11 and is located
downstream of the exons affected by
gene targeting (Figure 1c). There was
no significant difference in LAMB3
gene expression between the genotypes
(one-way analysis of variance,
P¼0.995; Figure 1d). To characterize
the LAMB3 transcript in homozygous
knockin mice, a fraction of LAMB3
cDNA was amplified with primers
located in exons 6 and 9 (Figure 1c).
The expected PCR product of 413 bp
was obtained from cDNA of wild-type
mice (Figure 1e), but also from dif-
ferent samples of heterozygous LAMB3
628G4A knockin mice (Figure 1e).
PCR analysis of homozygous LAMB3
628G4A knockin mice yielded a
clearly shorter PCR product (Figure 1e).
DNA sequencing confirmed complete
deletion of exon 7 (64 bp) in the knockin
mice. This led to a frameshift and
a consecutive premature termination
codon (PTC) after eight amino acids
(p.V189NfsX8; Figure 1f).
Although more than half of the obser-
ved LAMB3 628G4A knockin mice
survived slightly longer than LAMB3-
IAP mice (Mu¨hle et al., 2006), none of
them survived the perinatal era, presu-
mably owing to alternative splicing.
Deletion of exon 7 introduces a PTC
leading most likely to a complete
absence of the laminin-332 b3 chain,
so that the phenotype resembles that of
knockout mice. Perinatal death may be
caused by severe skin lesions, abandon-
ment by the mother, reduced weight
gain, and dehydration.
The mutation LAMB3 628G4A pre-
disposes to alternative splicing events,
as it affects the last base of exon 7
(Pulkkinen et al., 1998). Missplicing
has been reported for some, but not all,
humans carrying the same mutation
(McGrath et al., 1995; Posteraro et al.,
1998). If it occurred, the correct mRNA
and aberrant forms coexisted or correct-
ing second site mutations leading to
in-frame exon skipping were detected
(Posteraro et al., 1998; Pasmooij et al.,
2007). In LAMB3 628G4A knockin
mice, however, cDNA analysis revealed
only one aberrant mRNA lacking exon 7
and carrying a PTC, which explains the
severe phenotype. Thus, a better mouse
model with a different hypomorphic
LAMB3 mutation is needed that is
independent of unexpected splicing
variability.
Nevertheless, the LAMB3 628G4A
knockin mouse has been characterized
as a new mouse model of JEB, which
may prove useful for defining genetic
modifiers of the phenotype and contri-
bute to a better understanding of the
molecular basis of this disease.
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Table 1. Phenotype of LAMB3 628G4A knockin (ki) mice
Genotype Survival time
Time to appearance
of first blister (hours) Weight loss (%)
Affected body
surface (%) Litter size (n) Remarks
ND 448 hours, o72 hours 15 7 5 11 (2) Cannibalized by mother
ki/ki 448 hours, o72 hours 15 0 10 9 Killed
ki/ki 448 hours, o72 hours 38 13 5 9 Killed
kiki 424 hours, o48 hours 24 7 25 9 Killed
ki/ki 424 hours, o48 hours 13 5 20 10 Killed
ki/ki 424 hours, o48 hours 24 7 25 9 Killed
ki/ki 424 hours, o48 hours 0 0 10 7 Found dead
ki/ki 424 hours, o48 hours 15 10 5 11 (2) Found dead
ki/ki 424 hours, o48 hours — 1 0 11 (2) Found dead
ki/ki o24 hours 0 0 10 7 Killed
ki/ki o24 hours 0 5 10 7 Found dead
ND o24 hours 0 11 10 10 Cannibalized by mother
ki/ki 0 — ND ? 3 Found dead
ki/ki 0 — ND ? 2 Found dead
Abbreviation: ND, not determined.
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